CVE-2023-22377
CVE-2023-22377 is a high-severity vulnerability in Fujitsu Tsclinical Define.xml Generator with a CVSS 3.x base score of 7.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-611.
Key facts
- Severity: High (CVSS 3.x base score 7.4)
- EPSS exploit prediction: 1% (48th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-611
- Affected product: Fujitsu Tsclinical Define.xml Generator
- Published:
- Last modified:
Description
Improper restriction of XML external entity reference (XXE) vulnerability exists in tsClinical Define.xml Generator all versions (v1.0.0 to v1.4.0) and tsClinical Metadata Desktop Tools Version 1.0.3 to Version 1.1.0. If this vulnerability is exploited, an attacker may obtain an arbitrary file which meets a certain condition by reading a specially crafted XML file.
Frequently asked questions
- What is CVE-2023-22377?
- Improper restriction of XML external entity reference (XXE) vulnerability exists in tsClinical Define.xml Generator all versions (v1.0.0 to v1.4.0) and tsClinical Metadata Desktop Tools Version 1.0.3 to Version 1.1.0. If this vulnerability is exploited, an attacker may obtain an arbitrary file which meets a certain condition by reading a specially crafted XML file.
- How severe is CVE-2023-22377?
- CVE-2023-22377 has a CVSS 3.x base score of 7.4, rated high severity. It is exploitable over network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.
- Is CVE-2023-22377 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (48th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-22377?
- CVE-2023-22377 primarily affects Fujitsu Tsclinical Define.xml Generator. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
- How do I fix CVE-2023-22377?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2023-22377 published?
- CVE-2023-22377 was published on 2023-02-15 and last updated on 2026-06-17.
References
Affected products (2)
- cpe:2.3:a:fujitsu:tsclinical_define.xml_generator:*:*:*:*:*:*:*:*
- cpe:2.3:a:fujitsu:tsclinical_metadata_desktop_tools:*:*:*:*:*:*:*:*
Other CWE-611 (Improper Restriction of XML External Entity Reference (XXE)) vulnerabilities
- CVE-2022-22486 — Critical (CVSS 10.0): IBM Tivoli Workload Scheduler 9.4, 9.5, and 10.1 is vulnerable to an XML External Entity Injection (XXE) attack when…
- CVE-2019-14678 — Critical (CVSS 10.0): SAS XML Mapper 9.45 has an XML External Entity (XXE) vulnerability that can be leveraged by malicious attackers in…
- CVE-2015-9280 — Critical (CVSS 10.0): MailEnable before 8.60 allows XXE via an XML document in the request.aspx Options parameter.
- CVE-2018-1000838 — Critical (CVSS 10.0): autopsy version <= 4.9.0 contains a XML External Entity (XXE) vulnerability in CaseMetadata XML Parser that can result…
- CVE-2018-1000837 — Critical (CVSS 10.0): UML Designer version <= 8.0.0 contains a XML External Entity (XXE) vulnerability in XML parser for plugins that can…
- CVE-2018-1000835 — Critical (CVSS 10.0): KeePassDX version <= 2.5.0.0beta17 contains a XML External Entity (XXE) vulnerability in kdbx file parser that can…
Browse all CWE-611 (Improper Restriction of XML External Entity Reference (XXE)) vulnerabilities →